New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 20, 2013
08:34 EDTRTIXRTI Biologics' BioCleanse allografts show positive clinical results
RTI Biologics announced results of a recent randomized prospective clinical study of BioCleanse-processed bone-patellar tendon-bone allografts used in anterior cruciate ligament reconstruction surgery. The study compares the clinical outcomes of BTB allografts processed using RTIís patented BioCleanse Tissue Sterilization Process with a control group consisting of aseptically-processed allografts from the three U.S. tissue banks that provide this type of allograft. Results indicate that the sterilization process, BioCleanse, did not demonstrate a statistical difference in clinical outcomes for the BTB allograft at two years. The BioCleanse process may provide surgeons with allografts clinically similar to aseptically-processed allograft tissue with the benefit of addressing donor-to-recipient disease.
News For RTIX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2015
08:11 EDTRTIXRTI Surgical sees Q3 EPS 5c, consensus 5c
Subscribe for More Information
08:10 EDTRTIXRTI Surgical narrows FY15 EPS view to 20c-23c from 19c-23
Subscribe for More Information
08:09 EDTRTIXRTI Surgical reports Q2 EPS 5c, consensus 4c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use